RP, G., J, W., HL, H., AC, H., R, C., & J, P. (2017). Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: Results of a phase II randomized trial. Dove Medical Press.
Style de citation Chicago (17e éd.)RP, Gallemore, Wallsh J, Hudson HL, Ho AC, Chace R, et Pearlman J. Combination Verteporfin Photodynamic Therapy Ranibizumab-dexamethasone in Choroidal Neovascularization Due to Age-related Macular Degeneration: Results of a Phase II Randomized Trial. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)RP, Gallemore, et al. Combination Verteporfin Photodynamic Therapy Ranibizumab-dexamethasone in Choroidal Neovascularization Due to Age-related Macular Degeneration: Results of a Phase II Randomized Trial. Dove Medical Press, 2017.